Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 5
2010 6
2011 13
2012 8
2013 1
2014 3
2015 4
2016 8
2017 11
2018 9
2019 13
2020 4
2021 6
2022 7
2023 12
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Natural products in drug discovery: advances and opportunities.
Atanasov AG, Zotchev SB, Dirsch VM; International Natural Product Sciences Taskforce; Supuran CT. Atanasov AG, et al. Nat Rev Drug Discov. 2021 Mar;20(3):200-216. doi: 10.1038/s41573-020-00114-z. Epub 2021 Jan 28. Nat Rev Drug Discov. 2021. PMID: 33510482 Free PMC article. Review.
Oral microbiota and Alzheimer's disease: Do all roads lead to Rome?
Sureda A, Daglia M, Argüelles Castilla S, Sanadgol N, Fazel Nabavi S, Khan H, Belwal T, Jeandet P, Marchese A, Pistollato F, Forbes-Hernandez T, Battino M, Berindan-Neagoe I, D'Onofrio G, Nabavi SM. Sureda A, et al. Among authors: d onofrio g. Pharmacol Res. 2020 Jan;151:104582. doi: 10.1016/j.phrs.2019.104582. Epub 2019 Nov 30. Pharmacol Res. 2020. PMID: 31794871 Review.
A genome-wide association meta-analysis of all-cause and vascular dementia.
Mega Vascular Cognitive Impairment and Dementia (MEGAVCID) consortium. Mega Vascular Cognitive Impairment and Dementia (MEGAVCID) consortium. Alzheimers Dement. 2024 Sep;20(9):5973-5995. doi: 10.1002/alz.14115. Epub 2024 Jul 24. Alzheimers Dement. 2024. PMID: 39046104 Free PMC article.
Daidzein and its Effects on Brain.
Ahmed T, Javed S, Tariq A, Budzyńska B, D'Onofrio G, Daglia M, Nabavi SF, Nabavi SM. Ahmed T, et al. Among authors: d onofrio g. Curr Med Chem. 2017;24(4):365-375. doi: 10.2174/0929867323666161101140214. Curr Med Chem. 2017. PMID: 27804870 Review.
Phosphodiesterase inhibitors say NO to Alzheimer's disease.
Nabavi SM, Talarek S, Listos J, Nabavi SF, Devi KP, Roberto de Oliveira M, Tewari D, Argüelles S, Mehrzadi S, Hosseinzadeh A, D'onofrio G, Orhan IE, Sureda A, Xu S, Momtaz S, Farzaei MH. Nabavi SM, et al. Among authors: d onofrio g. Food Chem Toxicol. 2019 Dec;134:110822. doi: 10.1016/j.fct.2019.110822. Epub 2019 Sep 16. Food Chem Toxicol. 2019. PMID: 31536753 Review.
Emerging biomarkers and screening for cognitive frailty.
Ruan Q, D'Onofrio G, Sancarlo D, Greco A, Lozupone M, Seripa D, Panza F, Yu Z. Ruan Q, et al. Among authors: d onofrio g. Aging Clin Exp Res. 2017 Dec;29(6):1075-1086. doi: 10.1007/s40520-017-0741-8. Epub 2017 Mar 4. Aging Clin Exp Res. 2017. PMID: 28260159 Review.
Apigenin as neuroprotective agent: Of mice and men.
Nabavi SF, Khan H, D'onofrio G, Šamec D, Shirooie S, Dehpour AR, Argüelles S, Habtemariam S, Sobarzo-Sanchez E. Nabavi SF, et al. Among authors: d onofrio g. Pharmacol Res. 2018 Feb;128:359-365. doi: 10.1016/j.phrs.2017.10.008. Epub 2017 Oct 18. Pharmacol Res. 2018. PMID: 29055745 Review.
Neuroprotective Effects of Quercetin: From Chemistry to Medicine.
Barreca D, Bellocco E, D'Onofrio G, Nabavi SF, Daglia M, Rastrelli L, Nabavi SM. Barreca D, et al. Among authors: d onofrio g. CNS Neurol Disord Drug Targets. 2016;15(8):964-975. doi: 10.2174/1871527315666160813175406. CNS Neurol Disord Drug Targets. 2016. PMID: 27528470 Review.
98 results